Pharmaceutical

Symbiotic.blue Launches to Combine Oxford and Cambridge Scientific Brain Power with Bioentrepreneurial Leadership to Reinvent AI Drug Discovery

LONDON, June 19, 2025 (GLOBE NEWSWIRE) -- Symbiotic.blue, the UK’s newest Techbio company has launched to innovate a next-generation artificial…

6 months ago

111, Inc. Announces First Quarter 2025 Unaudited Financial Results

Maintained Quarterly Operational ProfitabilityOperating Expenses as a Percentage of Revenues Decreased 30 Basis Points YoYMaintained Quarterly Positive Operating Cash FlowSHANGHAI,…

6 months ago

The Department of Health – Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi

On the sidelines of a high-level US visit focused on healthcare innovation ABU DHABI, UAE, June 18, 2025 /PRNewswire/ --…

6 months ago

Cardiac Marker Testing Market Poised for Steady Growth, Driven by Point-of-Care Expansion

ARLINGTON, Va., June 18, 2025 /PRNewswire/ -- The global cardiac marker testing market is on track for sustained growth, according…

6 months ago

SandboxAQ Unveils SAIR, (Structurally Augmented IC50 Repository), a Novel Open Dataset of Protein-Ligand Structures Labelled By Binding Affinities

PALO ALTO, Calif., June 18, 2025 /PRNewswire/ -- SandboxAQ today announced the launch of SAIR (Structurally Augmented IC50 Repository), the…

6 months ago

Oklahoma Cancer Specialists and Research Institute Selects BioCareSD and AllyGPO as Primary Drug Distributor and GPO Partner

TULSA, Okla., June 18, 2025 /PRNewswire/ -- Oklahoma Cancer Specialists and Research Institute (OCSRI), a leading independent community oncology practice, has…

6 months ago

Petauri™ Further Expands Global Pricing and Market Access Capabilities With Key Leadership Hires

Rapidly growing pharmaceutical services platform announces the addition of accomplished executives to the organization's global pricing and market access team.…

6 months ago

START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials

The new platform is designed to break down barriers to early-phase trial access, bringing "Hope Through Access" to communities and…

6 months ago

Blue Earth Diagnostics Reinforces Leadership in Prostate Cancer Imaging and Highlights Expanding Pipeline at Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025

BOSTON, June 18, 2025 /PRNewswire/ -- Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of…

6 months ago

EY 2025 Biotech Beyond Borders Report: Biopharma — Focus on fundamentals to bounce back

Shifting policy environment creates regulatory and funding challenges: Policy changes will continue to cause uncertainty for the broader industry and…

6 months ago